Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma.
Int J Mol Sci
; 22(6)2021 Mar 17.
Article
in En
| MEDLINE
| ID: mdl-33802643
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Signal Transduction
/
Chemokine CCL20
/
TOR Serine-Threonine Kinases
/
Docetaxel
/
Squamous Cell Carcinoma of Head and Neck
/
Head and Neck Neoplasms
Limits:
Animals
/
Humans
Language:
En
Journal:
Int J Mol Sci
Year:
2021
Type:
Article
Affiliation country:
Taiwan